These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

108 related items for PubMed ID: 9209450

  • 1. Anaplastic large cell lymphomas expressing the novel chimeric protein p80NPM/ALK: a distinct clinicopathologic entity.
    Shiota M, Mori S.
    Leukemia; 1997 Apr; 11 Suppl 3():538-40. PubMed ID: 9209450
    [Abstract] [Full Text] [Related]

  • 2. Anaplastic large cell lymphomas expressing the novel chimeric protein p80NPM/ALK: a distinct clinicopathologic entity.
    Shiota M, Nakamura S, Ichinohasama R, Abe M, Akagi T, Takeshita M, Mori N, Fujimoto J, Miyauchi J, Mikata A, Nanba K, Takami T, Yamabe H, Takano Y, Izumo T, Nagatani T, Mohri N, Nasu K, Satoh H, Katano H, Fujimoto J, Yamamoto T, Mori S.
    Blood; 1995 Sep 01; 86(5):1954-60. PubMed ID: 7655022
    [Abstract] [Full Text] [Related]

  • 3. The clinicopathological features of anaplastic large cell lymphomas expressing p80NPM/ALK.
    Shiota M, Mori S.
    Leuk Lymphoma; 1996 Sep 01; 23(1-2):25-32. PubMed ID: 9021682
    [Abstract] [Full Text] [Related]

  • 4. Anaplastic large cell lymphoma: a distinct molecular pathologic entity: a reappraisal with special reference to p80(NPM/ALK) expression.
    Nakamura S, Shiota M, Nakagawa A, Yatabe Y, Kojima M, Motoori T, Suzuki R, Kagami Y, Ogura M, Morishima Y, Mizoguchi Y, Okamoto M, Seto M, Koshikawa T, Mori S, Suchi T.
    Am J Surg Pathol; 1997 Dec 01; 21(12):1420-32. PubMed ID: 9414185
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Ki-1 lymphoma].
    Nakamura S, Ichimura K, Sasaki K, Suzuki R.
    Nihon Rinsho; 2000 Mar 01; 58(3):650-4. PubMed ID: 10741140
    [Abstract] [Full Text] [Related]

  • 8. Differential expression of BCL-2 family proteins in ALK-positive and ALK-negative anaplastic large cell lymphoma of T/null-cell lineage.
    Rassidakis GZ, Sarris AH, Herling M, Ford RJ, Cabanillas F, McDonnell TJ, Medeiros LJ.
    Am J Pathol; 2001 Aug 01; 159(2):527-35. PubMed ID: 11485911
    [Abstract] [Full Text] [Related]

  • 9. The (2;5)(p23;q35) translocation in cell lines derived from malignant lymphomas: absence of t(2;5) in Hodgkin-analogous cell lines.
    Dirks WG, Zaborski M, Jäger K, Challier C, Shiota M, Quentmeier H, Drexler HG.
    Leukemia; 1996 Jan 01; 10(1):142-9. PubMed ID: 8558920
    [Abstract] [Full Text] [Related]

  • 10. High incidence of the t(2;5)(p23;q35) translocation in anaplastic large cell lymphoma and its lack of detection in Hodgkin's disease. Comparison of cytogenetic analysis, reverse transcriptase-polymerase chain reaction, and P-80 immunostaining.
    Lamant L, Meggetto F, al Saati T, Brugières L, de Paillerets BB, Dastugue N, Bernheim A, Rubie H, Terrier-Lacombe MJ, Robert A, Rigal F, Schlaifer D, Shiuta M, Mori S, Delsol G.
    Blood; 1996 Jan 01; 87(1):284-91. PubMed ID: 8547653
    [Abstract] [Full Text] [Related]

  • 11. Mapping of genomic t(2;5)(p23;q35) break points in patients with anaplastic large cell lymphoma by sequencing long-range PCR products.
    Luthra R, Pugh WC, Waasdorp M, Morris W, Cabanillas F, Chan PK, Sarris AH.
    Hematopathol Mol Hematol; 1998 Jan 01; 11(3-4):173-83. PubMed ID: 9844824
    [Abstract] [Full Text] [Related]

  • 12. Analysis of gene expression profile of TPM3-ALK positive anaplastic large cell lymphoma reveals overlapping and unique patterns with that of NPM-ALK positive anaplastic large cell lymphoma.
    Bohling SD, Jenson SD, Crockett DK, Schumacher JA, Elenitoba-Johnson KS, Lim MS.
    Leuk Res; 2008 Mar 01; 32(3):383-93. PubMed ID: 17720243
    [Abstract] [Full Text] [Related]

  • 13. Inhibition of tyrosine kinase activity induces caspase-dependent apoptosis in anaplastic large cell lymphoma with NPM-ALK (p80) fusion protein.
    Ergin M, Denning MF, Izban KF, Amin HM, Martinez RL, Saeed S, Alkan S.
    Exp Hematol; 2001 Sep 01; 29(9):1082-90. PubMed ID: 11532349
    [Abstract] [Full Text] [Related]

  • 14. Downregulation of NPM-ALK by siRNA causes anaplastic large cell lymphoma cell growth inhibition and augments the anti cancer effects of chemotherapy in vitro.
    Hsu FY, Zhao Y, Anderson WF, Johnston PB.
    Cancer Invest; 2007 Jun 01; 25(4):240-8. PubMed ID: 17612934
    [Abstract] [Full Text] [Related]

  • 15. The monoclonal antibody ALK1 identifies a distinct morphological subtype of anaplastic large cell lymphoma associated with 2p23/ALK rearrangements.
    Pittaluga S, Wlodarska I, Pulford K, Campo E, Morris SW, Van den Berghe H, De Wolf-Peeters C.
    Am J Pathol; 1997 Aug 01; 151(2):343-51. PubMed ID: 9250148
    [Abstract] [Full Text] [Related]

  • 16. Childhood anaplastic large cell lymphoma has a high incidence of ALK gene rearrangement as determined by immunohistochemical staining and fluorescent in situ hybridisation: a genetic and pathological correlation.
    Perkins SL, Pickering D, Lowe EJ, Zwick D, Abromowitch M, Davenport G, Cairo MS, Sanger WG.
    Br J Haematol; 2005 Dec 01; 131(5):624-7. PubMed ID: 16351638
    [Abstract] [Full Text] [Related]

  • 17. Truncated ALK derived from chromosomal translocation t(2;5)(p23;q35) binds to the SH3 domain of p85-PI3K.
    Polgar D, Leisser C, Maier S, Strasser S, Rüger B, Dettke M, Khorchide M, Simonitsch I, Cerni C, Krupitza G.
    Mutat Res; 2005 Feb 15; 570(1):9-15. PubMed ID: 15680399
    [Abstract] [Full Text] [Related]

  • 18. Molecular variant of the NPM-ALK rearrangement of Ki-1 lymphoma involving a cryptic ALK splice site.
    Ladanyi M, Cavalchire G.
    Genes Chromosomes Cancer; 1996 Mar 15; 15(3):173-7. PubMed ID: 8721682
    [Abstract] [Full Text] [Related]

  • 19. Detection of t(2;5)(p23;q35) translocation by reverse transcriptase polymerase chain reaction and in situ hybridization in CD30-positive primary cutaneous lymphoma and lymphomatoid papulosis.
    Beylot-Barry M, Lamant L, Vergier B, de Muret A, Fraitag S, Delord B, Dubus P, Vaillant L, Delaunay M, MacGrogan G, Beylot C, de Mascarel A, Delsol G, Merlio JP.
    Am J Pathol; 1996 Aug 15; 149(2):483-92. PubMed ID: 8701987
    [Abstract] [Full Text] [Related]

  • 20. The activated anaplastic lymphoma kinase increases cellular proliferation and oncogene up-regulation in rat 1a fibroblasts.
    Wellmann A, Doseeva V, Butscher W, Raffeld M, Fukushima P, Stetler-Stevenson M, Gardner K.
    FASEB J; 1997 Oct 15; 11(12):965-72. PubMed ID: 9337149
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.